Popular yogurt recalled; could contain sharp plastic pieces
Bread sold at Walmart and Kroger recalled
According to the recall alert, Danone U.S. is voluntarily recalling all flavors and sizes of YoCrunch products currently sold at retail stores nationwide.
Danone says consumers have reported finding plastic pieces in the 'dome toppers,' which are separate compartments containing the yogurts' toppings. Officials say only the separately packaged toppers are affected — not the separately packaged yogurt.
KFC offers free buckets of chicken in 'comeback'
'The plastic pieces are transparent, may have sharp edges, and could present a risk to consumers because some pieces are between 7 and 25 mm in length,' reads the alert. 'The company is working swiftly with retail partners to remove the impacted product from shelves, while it works to address the issue and bring back the YoCrunch® products so many people enjoy.'
Impacted product names and code dates, as provided by the FDA, are below.
YOCRUNCH STRAW W/GRANOLA 6OZ
(UPC 46675000105) 2025.07.07, 2025.07.12, 2025.07.26,
2025.08.03, 2025.08.08, 2025.08.19,
2025.08.22, 2025.08.30, 2025.09.04
YOCRUNCH VANILLA W/M&M 6OZ
(UPC 46675000792) 2025.07.11, 2025.07.14, 2025.07.25,
2025.08.07, 2025.08.11, 2025.08.22,
2025.08.26, 2025.09.03
YOCRUNCH VANILLA W/OREO 6OZ
(UPC 46675000808) 2025.07.11, 2025.07.14, 2025.07.24,
2025.07.25 2025.08.06, 2025.08.11,
2025.08.21, 2025.08.26, 2025.09.03
YOCRUNCH STRAW W/M&M 6OZ
(UPC 46675000839) 2025.07.12, 2025.07.25, 2025.08.07,
2025.08.22, 2025.09.04
YOCRUNCH VANILLA W/SNICKERS 6OZ
(UPC 46675001126) 2025.07.10, 2025.07.24, 2025.08.06,
2025.08.21
YOCRUNCH VANILLA W/TWIX CANDY 6OZ
(UPC 46675001133) 2025.07.24, 2025.08.07, 2025.08.21
YOCRUNCH STRAW W/M&M MULTI 4X4OZ
(UPC 46675013129) 2025.07.08, 2025.07.12, 2025.07.13,
2025.07.17, 2025.07.18, 2025.07.26,
2025.07.27, 2025.08.02, 2025.08.03,
2025.08.09, 2025.08.11, 2025.08.12,
2025.08.13, 2025.08.15, 2025.08.16,
2025.08.23, 2025.08.24, 2025.08.29,
2025.08.30, 2025.08.31
YOCRUNCH VAN W/COOKIE DOUGH 4X4OZ
(UPC 46675013150) 2025.07.17, 2025.08.01, 2025.08.13,
2025.08.29
YOCRUNCH VANI W/SNICKER PCS 4X4OZ
(UPC 46675013266) 2025.07.17, 2025.08.01, 2025.08.13,
2025.09.01
YOCRUNCH VANI W/TWIX CANDY 4X4OZ
(UPC 46675013273) 2025.07.17, 2025.08.01, 2025.08.14,
2025.08.29
YOCRUNCH VANILLA OREO 4X4OZ
(UPC 46675013501) 2025.07.13, 2025.07.14, 2025.07.20,
2025.07.21, 2025.07.24, 2025.07.25,
2025.07.26, 2025.07.31, 2025.08.01,
2025.08.02, 2025.08.08, 2025.08.09,
2025.08.10, 2025.08.11, 2025.08.15,
2025.08.16, 2025.08.23, 2025.08.24,
2025.08.25, 2025.08.30, 2025.08.31
YOCRUNCH VANILLA M&M 4X4OZ
(UPC 46675013518) 2025.07.07, 2025.07.09, 2025.07.14,
2025.07.15, 2025.07.16, 2025.07.17,
2025.07.22, 2025.07.23, 2025.07.26,
2025.07.27, 2025.07.28, 2025.08.02,
2025.08.03, 2025.08.05, 2025.08.06,
2025.08.07, 2025.08.10, 2025.08.13,
2025.08.14, 2025.08.16, 2025.08.17,
2025.08.18, 2025.08.19, 2025.08.20,
2025.08.21, 2025.08.22, 2025.08.26,
2025.08.27, 2025.08.28, 2025.08.29,
2025.09.01, 2025.09.02, 2025.09.03,
2025.09.04
YOCRUNCH VAN OREO & M&M FR PK 8X6OZ
(UPC 46675014003) 2025.07.12, 2025.07.13, 2025.07.14,
2025.07.15, 2025.07.16, 2025.07.20,
2025.07.21, 2025.07.22, 2025.07.23,
2025.07.24, 2025.07.25, 2025.07.28,
2025.08.02, 2025.08.03, 2025.08.04,
2025.08.05, 2025.08.06, 2025.08.07,
2025.08.10, 2025.08.11, 2025.08.12,
2025.08.13, 2025.08.14, 2025.08.17,
2025.08.18, 2025.08.19, 2025.08.20,
2025.08.21, 2025.08.22, 2025.08.23,
2025.08.25, 2025.08.26, 2025.08.27,
2025.08.28, 2025.08.29, 2025.09.02
YOCRUNCH STR/RAS GRNLA FR PK 8X6OZ
(UPC 46675014010) 2025.07.26, 2025.08.23, 2025.08.30
YOCRUNCH STRW W/M&M&OREO FR PK 8X6OZ
(UPC 46675026136) 2025.07.22, 2025.08.03, 2025.08.19,
2025.08.29
YOCRUNCH VAN W/SNIC&TWIX FR PK 8X6OZ
(UPC 46675026143) 2025.07.14, 2025.07.28, 2025.08.11,
2025.08.26
YOCRUNCH VAN OREO/VAN M&M 18X6OZ CLB
(UPC 46675027010) 2025.07.11, 2025.07.19, 2025.07.20,
2025.07.26, 2025.07.27, 2025.07.28,
2025.07.31, 2025.08.01, 2025.08.02,
2025.08.08, 2025.08.09, 2025.08.16,
2025.08.17, 2025.08.23, 2025.08.24,
2025.08.25, 2025.08.30, 2025.08.31
Consumers who have purchased the affected products are urged not to eat them.
'Danone U.S., the makers of YoCrunch, takes every consumer experience seriously and is initiating this voluntary recall in line with its commitment to product quality and consumer safety,' reads the recall alert.
For information on refunds, contact the YoCrunch Consumer Care Line at 1-877-344-4886.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
5 hours ago
- Associated Press
UNCY Investors Have Opportunity to Join Unicycive Therapeutics, Inc. Fraud Investigation With the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--Jul 19, 2025-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Unicycive Therapeutics, Inc. ('Unicycive' or 'the Company') (NASDAQ: UNCY ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Unicycive announced on June 30, 2025, that the FDA 'has issued a CRL [Complete Response Letter] for its New Drug Application (NDA) for OLC to treat hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis.' The Company added that 'After submitting the NDA, and as a part of the application review and routine information requests, the FDA notified Unicycive that a third-party manufacturing vendor of its main contract development and manufacturing organization (CDMO) was cited for deficiencies following a cGMP inspection.' Based on this news, shares of Unicycive fell by 29.85% on the same day. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at [email protected]. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. View source version on CONTACT: The Schall Law Firm Brian Schall, Esq. 310-301-3335 [email protected] KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL SOURCE: Schall Law Firm Copyright Business Wire 2025. PUB: 07/19/2025 02:19 PM/DISC: 07/19/2025 02:19 PM
Associated Press
a day ago
- Associated Press
Juul gets FDA's OK to keep selling tobacco and menthol e-cigarettes
WASHINGTON (AP) — The Food and Drug Administration is allowing vaping brand Juul to keep its e-cigarettes on the market, providing relief to a company that has struggled for years after being widely blamed for sparking the teen vaping trend. FDA regulators said Thursday that Juul's studies show its e-cigarettes are less harmful for adult smokers, who can benefit from switching completely to vaping. The FDA decision applies to both tobacco- and menthol-flavored versions of the reusable product, which works with nicotine-filled cartridges sold in two different strengths. Juul previously discontinued several fruit and candy flavors that helped drive its popularity but were favored by teens. Juul will be one of only two U.S. companies authorized to sell menthol-flavored vapes, which many adults prefer to tobacco flavor. 'This is an important milestone for the company and I think we made a scientifically sound case for the role that menthol can play in e-vapor,' Juul CEO K.C. Crosthwaite told The Associated Press. Parents, politicians and anti-tobacco groups are certain to oppose FDA's decision. They have argued for years that Juul products should be permanently banned due to their role in triggering a yearslong spike in underage vaping. 'It is a big step in the wrong direction to authorize sales of the product that was responsible for this public health crisis in the first place,' said Yolonda Richardson, CEO of the Campaign for Tobacco-Free Kids in a statement. Juul was once valued at over $13 billion and its small, sleek e-cigarettes revolutionized the image and technology of the vaping industry. But the company has since been forced to slash hundreds of jobs and pay billions to settle lawsuits over its role in the rise of youth vaping. The FDA had ordered the company to remove its products from the market in June 2022. But then the agency abruptly reversed course days later and agreed to reopen its scientific review of Juul's application after the company pushed back in court. Juul said that regulators had overlooked thousands of pages of scientific data critical to its submission. Thursday's announcement is not an approval or endorsement, and the FDA reiterated that people who do not smoke should not use Juul or any other e-cigarettes. The FDA determination indicates that smokers who switch completely to Juul can reduce their exposure to deadly carcinogens and other chemicals found in traditional cigarettes. The FDA decision applies to Juul's original system, which is now roughly a decade old. Crosthwaite said the company hopes to win authorization for its next-generation device and is also considering applying to FDA for more flavors. 'It's critically important that American adults who use tobacco have regulated options,' Crosthwaite said. In recent years, the FDA has authorized a handful of e-cigarettes to help adult smokers cut back on cigarettes. Juul's main competitors, Vuse and Njoy, each previously received FDA permission to remain on the market. Njoy sells the only other menthol-flavored e-cigarettes authorized by FDA. To meet FDA requirements, companies must show that their products benefit public health. In practice, that means proving that adult smokers who use them are likely to quit or reduce their smoking, while teens are unlikely to get hooked on them. The brainchild of two Stanford University students, Juul launched in 2015 and within two years rocketed to the top of the vaping market. Juul quickly outpaced older brands with its high-nicotine, fruity-flavored cartridges, sold in mango, mint and creme brulé. The company's small, discrete devices provided a more potent, user-friendly alternative to older, bulkier devices. But the company's rise was fueled by underage use, and e-cigarettes quickly became ubiquitous in U.S. schools. In 2019, the company was pressured into halting all advertising and eliminating most of its flavors, leaving only tobacco and menthol-flavored options. By then the company was already the target of multiple investigations and lawsuits by federal, state and local officials as well as class action attorneys. In 2022, the company paid $1.7 billion to settle thousands of lawsuits brought by families of Juul users, school districts, city governments and Native American tribes. The company separately agreed to pay $1.1 billion to settle lawsuits or investigations from most U.S. states. Juul is no longer the top-selling e-cigarette brand and now trails Vuse, which is sold by tobacco giant Reynolds American, which also makes Camel and Newport cigarettes. Teens have shifted away from Juul amid a wider drop in vaping, according to the latest federal figures. The FDA reported last year that teen vaping dropped to a 10-year low, after stepped up enforcement against unauthorized brands imported from China, such as Elf Bar.
Yahoo
a day ago
- Yahoo
CrowdStrike (CRWD) Expands AWS Partnership to Power AI Security Solutions
CrowdStrike Holdings, Inc. (NASDAQ:CRWD) is one of the . On July 16, Crowdstrike announced an expanded collaboration with Amazon Web Services (AWS) to fast-track AI adoption in cybersecurity and secure AI use. Under the collaboration, Crowdstrike's new tools, the falcon-mcp, which is an MCP server for the CrowdStrike Falcon® platform, and CrowdStrike AI Red Team Services, are available under the new AI Agents and Tools category of AWS Marketplace. These tools will help AWS customers to operationalize agentic AI workflow integrations, as well as safely test and protect AI systems within their existing AWS environment. With AI adoptions accelerating, offering realistic ways to connect models to real-time security operations has become a critical need. Trusted frameworks such as those from Crowdstrike can help companies power their security operations and protect the AI systems those operations depend on. A trust services representative using modern technology for improved financial security. 'Agentic AI is fundamentally changing business of all sizes across every industry – but only secure AI can safely scale to deliver long-term results. With these offerings now available in AWS Marketplace, CrowdStrike is giving customers the power to safely build, test, and run AI-driven security workflows using the same cybersecurity platform trusted to protect the world's most critical environments.' -Daniel Bernard, chief business officer, CrowdStrike. CrowdStrike Holdings, Inc. (NASDAQ:CRWD) is a leader in AI-driven endpoint and cloud workload protection. While we acknowledge the potential of CRWD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
